We were proud to participate in ISPOR Europe 2025 in Glasgow, Scotland one of the world’s leading congresses for Health Economics and Outcomes Research (HEOR).This year, Health Through Evidence presented six research posters, reflecting our expanding footprint across real-world evidence, HEOR, public health, and AI-driven analytics.
Our contributions at ISPOR Europe 2025 included:
1. Screening and Diagnosis of Paroxysmal Nocturnal Hemoglobinuria in Greece: Consensus Recommendations From a Multispecialty Expert Panel
Authors: V. Antonopoulou, G. Gourzoulidis, M. Angelopoulou, E. Dounousi, E. Gavriilaki, G. Giannakoulas, O. Giouleme, J. Koskinas, Z. Kratiras, E. Liberopoulos, E. Solomou, K. Konstantopoulou, C. Tzanetakos
🔗 Find out more at View the study
2. Exploring the Broader Value of Adult Respiratory Vaccination Programs in Greece: A Public Health Perspective
Authors: A. Solakidi, V. Kossyvaki, I. Antoniou, G. Gourzoulidis, C. Tzanetakos, T. Hu, D. Mendes, M. Napier, S. Brassel, L. Steuten
🔗 Find out more at View the study
3. Reliability and Validity of the Greek Version of PedsQL™ 30 Duchenne Muscular Dystrophy Module in Children With Duchenne Muscular Dystrophy
Authors: E. Katsomiti, C. Kastanioti, E. Chroni, G. Mavridoglou, G. Gourzoulidis
🔗 Find out more at View the study
4. Prevalence, Utilization Patterns and Economic Impact of EGFR and ALK-Targeted Therapies in NSCLC: A Nationwide RWE Analysis From Greece
Authors: G. Gourzoulidis, C. Kastanioti, G. Mavridoglou, T. Kotsilieris, A. Tsolakidis, K. Mathioudakis, D. Voudigaris, C. Tzanetakos
🔗 Find out more at View the study
5. Disease Burden of Respiratory Syncytial Virus Among Adults in Greece
Authors: A. Solakidi, E. Markatis, D. Mendes, G. Gourzoulidis, C. Tzanetakos
🔗 Find out more at View the study
6. Artificial Intelligence in Health Economics: Opportunities and Challenges . A Targeted Literature Review
Authors: G. Gourzoulidis, C. Kastanioti, G. Mavridoglou, T. Kotsilieris, D. Voudigaris, C. Tzanetakos
🔗 Find out more at View the study
ISPOR Europe 2025 provided a valuable opportunity to exchange ideas with global experts and reinforce our mission: to generate evidence that meaningfully improves health outcomes.
We extend our sincere thanks to everyone who visited our posters or engaged in discussion. Your feedback and collaboration continue to drive our scientific work forward.
